The global surrogacy market size was valued at USD 24.53 billion in 2025 and is projected to grow from USD 29.78 billion in 2026 to USD 140.39 billion by 2034, registering a CAGR of 21.39% during the forecast period from 2026 to 2034. North America dominated the surrogacy market with a market share of 38.4% in 2025.
Surrogacy is a form of assisted reproduction in which the intended parents collaborate with a surrogate who carries the embryo to term. Surrogacy utilizes both conventional and gestational-assisted reproductive technologies. Traditional technology utilizes the surrogate's eggs, making her the child's biological mother. During gestation, the surrogate has no biological connection to the unborn child. As the majority of altruistic surrogacy agreements involve close relatives of the intended parents, a surrogate does not receive monetary compensation. The industry includes both charitable and commercial activities.
Download a Free Sample To learn more about this report,
Growing Adoption of Structured Gestational Surrogacy Programs
Gestational surrogacy is becoming a more structured form of assisted reproduction as fertility centers combine IVF, embryo cryopreservation, medical screening, counseling, legal coordination, and gestational-carrier management within specialized programs. Unlike traditional surrogacy, the gestational carrier has no genetic relationship with the child because the pregnancy is established using an embryo created through IVF. Greater clinical standardization is helping intended parents and carriers navigate increasingly complex medical and legal requirements.
Greater standardization of clinical and legal procedures is becoming one of the important surrogacy market trends, supporting more professionally managed gestational-carrier programs.
Increasing Digitalization of Surrogacy and ART Regulation
Governments are increasingly digitalizing the registration and monitoring of fertility clinics, ART centers, and surrogacy services. Online regulatory platforms can simplify licensing, document submission, inspection tracking, compliance monitoring, and communication between clinics and authorities. Greater digital oversight can also improve transparency and make it easier for regulators to identify non-compliant providers.
The increasing use of digital regulatory infrastructure is encouraging greater transparency and accountability across the surrogacy industry.
Rising Need for Infertility Treatment and Advanced Reproductive Care
Infertility remains an important reproductive-health issue, with approximately one in six people of reproductive age worldwide experiencing infertility during their lifetime. Medical conditions that prevent pregnancy, recurrent pregnancy loss, absence or abnormalities of the uterus, and other reproductive factors can make gestational surrogacy an option for some patients. Growing awareness and availability of IVF, embryo freezing, donor services, and fertility treatment are therefore supporting surrogacy market growth where the practice is legally permitted.
Greater recognition of infertility and expansion of evidence-based fertility services can strengthen surrogacy market demand among medically eligible patients who cannot safely carry a pregnancy.
Strict Eligibility Requirements and Surrogacy Regulations
Surrogacy laws differ considerably between jurisdictions and can impose restrictions based on age, marital status, nationality, medical eligibility, compensation, or the relationship between intended parents and the surrogate. Even when IVF technology and qualified gestational carriers are available, legal restrictions can prevent intended parents from accessing treatment. These requirements can reduce the eligible patient population and restrict the surrogacy market size.
Strict eligibility rules can consequently limit access and increase the legal and administrative complexity associated with surrogacy arrangements.
Strengthening Quality and Safety Standards Across Fertility Services
Growing attention to clinical quality, informed consent, donor management, patient privacy, laboratory standards, and medical safeguards is creating opportunities for professionally managed fertility and surrogacy services. Stronger standards can improve patient confidence while encouraging clinics to invest in qualified professionals, laboratory infrastructure, documentation, counseling, and transparent treatment processes.
Providers capable of meeting stronger medical and ethical standards could strengthen their surrogacy market share as patients increasingly prioritize transparent, clinically supervised, and compliant reproductive services.
Cross-Border Legal Differences and Restrictions on Intended Parents
Cross-border surrogacy remains difficult because laws governing gestational-carrier arrangements differ substantially between jurisdictions. Intended parents may face restrictions involving nationality, citizenship, residency, parentage recognition, contracts, immigration documentation, and the legal status of children born through surrogacy. A legally valid arrangement in one jurisdiction may therefore face complications elsewhere.
Managing differences in surrogacy laws while establishing clear parental rights and protecting gestational carriers and children will remain a significant challenge for the surrogacy industry, particularly for cross-border arrangements.
Gestational Surrogacy Segment Dominated the Market with 82.7% Share in 2025
The gestational surrogacy segment dominated the global surrogacy market with an 82.7% share in 2025, valued at USD 20.29 billion. In gestational surrogacy, an embryo created through IVF using eggs and sperm from the intended parents or donors is transferred to a gestational carrier who has no genetic relationship with the child. This approach is widely preferred because it separates the carrier's genetic contribution from the pregnancy and can accommodate different intended-parent and donor arrangements. Growing access to assisted reproductive technologies and specialized fertility clinics continues to support its adoption.
Traditional surrogacy represents a smaller segment because the surrogate's own egg is used, creating a genetic relationship between the carrier and the child. Differences in legal treatment, medical practices, and availability across countries and jurisdictions continue to influence its adoption.
Request Customizationto receive a tailored report.
IVF with ICSI Segment Dominated the Market with 57.8% Share in 2025
IVF with ICSI dominated the global market with a 57.8% share in 2025, valued at USD 14.18 billion. ICSI involves injecting a single sperm directly into an egg during the IVF process and is particularly useful when male-factor infertility, previous fertilization difficulties, or certain sperm-related conditions are present. Its integration with embryo creation and other assisted reproductive procedures makes it an important technology in gestational surrogacy programs.
IVF without ICSI remains widely used when conventional fertilization is clinically appropriate. In this procedure, eggs and sperm are combined in the laboratory and fertilization occurs without directly injecting sperm into the egg.
Intrauterine insemination represents a smaller portion of the segment and is primarily associated with traditional surrogacy arrangements. Its comparatively simpler procedure can make it suitable in specific circumstances, although its application depends heavily on individual medical and legal considerations.
Below 35 Years Segment Dominated the Market with 31.8% Share in 2025
The below 35 years segment dominated the global surrogacy market with a 31.8% share in 2025, valued at USD 7.80 billion. Age is an important consideration in assisted reproduction because egg quantity and quality generally decline as reproductive age increases. Intended parents below 35 may therefore have comparatively favorable reproductive potential when their own eggs are used during IVF procedures.
The 35–37 years segment represents another significant group as more people pursue parenthood later in life. Greater availability of fertility evaluation, IVF, embryo testing, egg freezing, and donor-assisted reproductive options is broadening treatment pathways for this age group.
The 38–39 years segment also accounts for notable demand as age-related fertility changes encourage some intended parents to explore assisted reproductive technologies and surrogacy after unsuccessful conception or fertility treatment.
Fertility Clinics Segment Dominated the Market with 64.3% Share in 2025
Fertility clinics dominated the global market with a 64.3% share in 2025, valued at USD 15.77 billion. Specialized clinics play a central role in surrogacy programs by providing fertility assessment, ovarian stimulation, egg retrieval, IVF and ICSI procedures, embryo culture, embryo transfer, cryopreservation, and reproductive counseling. Access to dedicated embryology laboratories and reproductive specialists further strengthens their position.
Hospitals remain important service providers, particularly when intended parents or gestational carriers require multidisciplinary medical support. Their broader clinical infrastructure can be valuable for managing pregnancies that require additional monitoring or specialized care.
Other service providers contribute through complementary services associated with assisted reproduction and surrogacy arrangements, although their role varies considerably depending on local healthcare systems and legal frameworks.
Speak to an Analystto discuss market opportunities.
North America surrogacy market accounted for 38.4% of the global market, reaching USD 9.42 billion in 2025, and is projected to grow at a CAGR of 17.2% during the forecast period. Growth is supported by increasing infertility cases, wider availability of assisted reproductive technologies, established fertility clinics, and growing use of gestational surrogacy. Advanced IVF procedures, embryo screening technologies, and increasing awareness of alternative family-building options continue to support regional market growth.
The US market was valued at USD 8.05 billion in 2025, making it the largest contributor in North America. A well-established fertility treatment ecosystem, availability of advanced IVF and embryo transfer procedures, and growing demand for gestational surrogacy continue to support market expansion. The presence of specialized fertility clinics and surrogacy agencies across states where supportive legal frameworks exist further strengthens demand.
Canada's market reached USD 1.01 billion in 2025. Growing utilization of fertility treatments, increasing awareness of assisted reproduction, and access to advanced reproductive healthcare services continue to support market development. Canada's altruistic surrogacy framework also provides a structured pathway for eligible intended parents seeking surrogacy arrangements.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe surrogacy market accounted for 27.6% of the global market, reaching USD 6.77 billion in 2025, and is projected to register a CAGR of 19.8% during the forecast period. Increasing infertility treatment demand, delayed parenthood, technological advancements in IVF, and greater awareness of assisted reproductive options are supporting regional growth. However, differences in national surrogacy laws continue to influence the availability and structure of services across European countries.
Germany's market accounted for USD 1.84 billion in 2025. Demand for assisted reproductive services is supported by delayed parenthood, fertility challenges, and access to sophisticated reproductive healthcare. However, domestic surrogacy is prohibited in Germany, leading intended parents interested in surrogacy to explore legally permitted arrangements in other jurisdictions.
The UK market was valued at USD 1.47 billion in 2025. Growing awareness of fertility treatment, increasing use of assisted reproductive technologies, and greater visibility of surrogacy as a family-building pathway continue to support demand. The country's legal framework permits altruistic surrogacy, while ongoing attention to parental rights and surrogacy arrangements continues to shape the sector.
Asia Pacific surrogacy market accounted for 23.5% of the global market, valued at USD 5.76 billion in 2025, and is projected to grow at a CAGR of 18.7% during the forecast period. Rising infertility rates, increasing fertility-treatment awareness, expanding IVF infrastructure, and improvements in reproductive technologies are supporting regional development. Regulatory differences between countries remain a major factor determining access to surrogacy services.
Japan's market generated USD 1.16 billion in 2025. Delayed marriage and parenthood, increasing demand for fertility treatments, and improvements in assisted reproductive technologies continue to support the broader reproductive healthcare sector. Surrogacy remains highly restricted in practice, making IVF and other fertility treatments more established options for individuals experiencing infertility.
China's market accounted for USD 2.53 billion in 2025, representing a major contribution within Asia Pacific. Rising maternal age, fertility challenges, and growing demand for assisted reproductive treatments are expanding the country's reproductive healthcare ecosystem. Surrogacy itself remains prohibited by regulations governing medical institutions, while demand for IVF and related fertility services continues to increase.
Latin America surrogacy market accounted for 6.4% of the global market, reaching USD 1.57 billion in 2025, and is projected to grow at a CAGR of 15.9% during the forecast period. Expansion of fertility clinics, increasing adoption of IVF, growing medical expertise, and rising awareness of reproductive healthcare options continue to support regional development. Regulatory conditions vary considerably between countries, influencing the accessibility of surrogacy arrangements.
Brazil's market was valued at USD 0.87 billion in 2025. An established network of fertility clinics, increasing utilization of assisted reproductive technologies, and growing awareness of infertility treatments continue to support demand. Gestational surrogacy is governed through medical and ethical rules that generally emphasize non-commercial arrangements and specific eligibility requirements.
Middle East & Africa surrogacy market accounted for 4.1% of the global market, totaling USD 1.01 billion in 2025, and is projected to register a CAGR of 14.8% during the forecast period. Expansion of fertility clinics, investment in advanced reproductive healthcare, increasing infertility awareness, and growing availability of IVF technologies are strengthening the broader fertility services sector. Surrogacy regulations, however, vary substantially across the region and remain restrictive in several countries.
The UAE market was valued at USD 0.30 billion in 2025. Investment in advanced fertility clinics, increasing access to IVF technologies, and rising demand for reproductive healthcare services continue to strengthen the fertility treatment ecosystem. Surrogacy remains legally restricted, meaning market activity is primarily associated with broader assisted reproductive services rather than domestic surrogacy procedures.
The global surrogacy industry is highly fragmented in nature due to the presence of specialized fertility clinics, reproductive healthcare networks, and surrogacy service providers competing across gestational surrogacy, IVF, surrogate matching, and related family-building services. The top players in the industry are New Hope Fertility Center, IVI RMA Global, NOVA IVI Fertility, Clinic Scanfert, Bourn Hall Fertility Clinic, Houston Fertility Center, Extraordinary Conceptions, Oasis Center, Care Fertility Group, Growing Generations LLC, Circle Surrogacy, New Life Global Network, International Surrogacy Center, Fertility Source Companies, and others.
The industry participants are inclined towards service expansion, strategic partnerships, and advanced assisted reproductive technologies to improve treatment access and patient outcomes. Providers are increasingly focusing on gestational surrogacy programs, IVF and ICSI, embryo cryopreservation, genetic testing, surrogate screening, legal coordination, and integrated fertility services while adapting their operations to different regulatory requirements across countries.
Indira IVF is a major fertility healthcare provider offering assisted reproductive services such as IVF, ICSI, embryo transfer, fertility preservation, and other reproductive treatments. Its expanding clinic network, embryology infrastructure, and standardized treatment protocols strengthen its ability to provide fertility services to a broader patient population.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Ambulance Services Market Size, Share, Growth, Analysis, 2034
North America Clinical Trial Imaging Market Size, Share, and Forecast 2034
Europe Clinical Trial Imaging Market Analysis, Trends, Forecast Up to 2034
Asia Pacific Clinical Trial Imaging Market Size, Share and Forecast to 2034
India Pharmaceutical Stability and Storage Services Market Size, Share & Trends | Industry Report, 2034
Healthcare Regulatory Affairs Outsourcing Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com